atorvastatin/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on serum adiponectin
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“Meta-analysis with a random-effect model showed that atorvastatin did not significantly affect circulating adiponectin as compared with controls (WMD = − 0.27 μg/mL, 95% CI: − 0.89 to 0.35 μg/mL, p = 0.39; Fig. 2a).”
Quoted verbatim from Effect of atorvastatin treatment on circulating adiponectin: a meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Dose
- 10 to 80 mg/day, 4 to 30 weeks
- Population
- Patients with various conditions (hyperlipidaemia, type 2 diabetes, hypertension, coronary artery disease, rheumatoid arthritis) in ten randomised trials, 14 datasets, oral atorvastatin versus placebo or blank control
Effect -0.27 mean difference, 95% CI -0.89 to 0.35
Effect of atorvastatin treatment on circulating adiponectin: a meta-analysis of randomized controlled trials.2019PMID:31870381Permalink
Keep reading
- Everything the graph holds on atorvastatin
- Every compound studied against Serum adiponectin
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45Z5PM8G47982GDNNJZPMGX